Investment Stage

Focus Areas

About Investor

Andrew Ng is Partner and Head of Healthcare at VMS Group in Hong Kong and also an Investment Partner at Panacea Venture. He typically backs growth-stage healthcare companies with $5.0M to $30.0M investments across therapeutics, biotech, medical devices, pharmaceuticals, health IT and healthcare services. His previous roles include Head of China Healthcare Equity Research at Barclays Capital and consulting at ZS Associates. He holds engineering degrees (BS and MEng) from Cornell University and an MBA from INSEAD, and has been recognized with industry awards for healthcare investing.